A US appeals court has found in favor of Masimo in its fight against Apple over pulse oximetry patents, but in the court that matters, a ruling makes it clear that there won't be another ban on the ...
Medtronic and GE HealthCare inked a multiyear deal to expand their more than three-decade- long partnership that aims to boost clinical and technology innovation. GE HealthCare is looking to adopt ...
Medtronic and Mindray North America expanded their partnership on patient monitoring technology beyond hospitals into ASCs in the United States, according to a Jan. 22 news release. The companies said ...
Garmin is intensifying its research into metabolic health with a newly published patent for non-invasive HbA1c estimation. The USPTO filing—granted in early February—describes a system that uses the ...
January 22, 2026 /3BL/ – Medtronic, a global leader in healthcare technology, announced verification study results for its investigational Nellcor™ pulse oximetry with Nell-EQ™ intelligent processor ...
Apple removed blood oxygen monitoring from the Apple Watch in early 2024. Somebody has to blink for it to return, and it looks like neither Masimo nor Apple are going to budge. Blood oxygen monitoring ...
Medtronic and Philips have re-upped their long-running partnership focused on bundling vital sign sensors together with patient monitoring equipment. The two medtechs said the collaboration extends ...
Medtronic (NYSE: MDT) + announced today that the FDA accepted its new Nellcor technology into its STeP program. The FDA Safer Technologies Program (STeP), a collaborative program, helps reduce the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results